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IGFBP-5201-218 stimulates Cdc42GAP aggregation and filopodia best-studied examples of cell movement, cells selectively
formation in migrating mesangial cells. attach to and release from the extracellular matrix (ECM)
Background. We have previously shown that insulin-like via specific integrin and nonintegrin receptors [2, 3]. Thegrowth factor-I (IGF-I) and IGF binding protein-5 (IGFBP-5)
plasma membrane of the receding tail of the cell is rap-induce mesangial cell migration using separate stimulatory and
idly internalized and is recycled and inserted into theeffector pathways. The IGFBP-5 stimulatory pathway is medi-
ated by the serine/threonine kinase IGFBP-5 receptor, which leading edge of the cell [4]. During chemotaxis, the lead-
is activated by the carboxy-terminal peptide IGFBP-5201-218. In ing edge of the cell (lamellipodium) becomes oriented
this study, we examined the direct effects of IGFBP-5201-218 on
toward a concentration gradient of a chemoattractantstimulatory and effector pathways that lead to a change in
[5]. The cytoskeletal reorganization that is responsiblemesangial cell (MC) phenotype.
Methods. Rapid actin reorganization, formation of filopodia, for this phenotype is mediated by the small GTPase
and characterization of novel substratum attachment structures Rac and is typical of migration stimulated by insulin-like
that develop during IGFBP-5–mediating migration were exam- growth factor-I (IGF-I) [6, 7] and platelet-derived growthined by light, immunofluorescence, and electron microscopy.
factor (PDGF) [7]. The other Rho-related GTPases, RhoUsing a wounding assay, migration was measured after the
and Cdc42, specifically mediate stress fiber and filpodiaaddition of stimulants and inhibitors.
Results. Stimulation of MCs with IGFBP-5201-218 induces rapid formation, respectively [8–10].
actin reorganization and loss of peripheral focal adhesions. The We recently reported that insulin [11] and IGF-I [12]
MCs develop long cellular extensions where f-actin and b-actin
modulate the cytoskeleton of rat glomerular mesangialterminate in unique substratum attachments. Fluorescence mi-
cells (MCs) and induce changes in the composition of thecroscopy of stimulated cells shows that Cdc42GAP aggregates
within minutes following treatment with IGFBP-5201-218. In con- ECM secreted by these cells [13, 14]. The IGF-I–induced
trast, IGF-I increases staining for Rac-1, but not Cdc42GAP, cytoskeletal changes mirrored those of directionally mi-
in association with the formation of prominent leading lamellae grating cells [12], and we subsequently demonstratedwithout filopodia. Staurosporin inhibits cell migration and
that IGF-I is chemotactic for MCs [15]. In studies under-Cdc42GAP aggregation only when added within the first hour,
taken to investigate the interactive effects of IGF-I andsuggesting that it inhibits the stimulatory effect of IGFBP-5201-218
by blocking the IGFBP-5 receptor serine/threonine kinase ac- IGF binding protein-5 (IGFBP-5), we demonstrated that
tivity. the amino-terminal region of IGFBP-5 inhibited IGF-I–
Conclusions. These data demonstrate that IGFBP-5201-218
induced chemotaxis, whereas the heparin-binding domainpreferentially activates Cdc42 and induces the formation of
within the carboxy-terminal region directly stimulatedlong filopodia with unique substratum attachments that pro-
duce a novel mode of locomotion. MC migration [15]. Furthermore, IGF-I and IGFBP-5
stimulated MC migration by different integrin/matrix at-
tachments, as demonstrated by the finding that the disin-
Cellular migration is essential to wound healing, angio- tegrin kistrin inhibited IGF-I– but not IGFBP-5–induced
genesis, development, and tumor metastasis [1]. In the migration. During these experiments, it was noted that
strikingly different cellular phenotypes were induced by
IGF-I and IGFBP-5, suggesting that each may stimulateKey words: Cdc4, GTPase, migration, insulin-like growth factor, cell
locomotion, filopodia. separate pathways of cytoskeletal reorganization. The
purpose of the present study was to examine the stimula-
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METHODS Experiments were repeated on three occasions. Data
were analyzed as the total number of migrating cells andMaterials
were expressed as a percentage of control.
The following reagents were purchased from the desig-
nated suppliers: Bodipy Phalloidin 503/512 (Molecular Cytoskeletal rearrangement
Probes, Eugene OR, USA); monoclonal mouse antivin- Mesangial cells (2 3 104) were plated in glass chamber
culin, monoclonal mouse anti–b-actin, and staurosporin slides, grown for 24 hours in 20% FCS-RPMI media,
(Sigma Biochemical, St. Louis, MO, USA); monoclonal and rested in 2% FCS-RPMI for 48 hours. MCs were
mouse anti-Cdc42GAP, monoclonal mouse anti-IQGAP1, treated with IGF-I (10 nmol/L), IGFBP-5 intact (30
and monoclonal mouse anti-Rac1 (Transduction Labora- nmol/L), IGFBP-5201-218 (30 mg/mL), or staurosporin (50
tory, Lexington, KY, USA); fluorescein-(FITC) and Cy 3- nmol/L) alone or in combinations and at designated
conjugated rabbit antimouse IgG (Jackson Labs, West times. MCs were fixed and examined by light, immuno-
Grove, PA, USA); chambered tissue culture glass slides fluorescence, or electron microscopy.
and tissue culture inserts (NUNC, Naperville, IL, USA);
Fluoromountt (Fisher Scientific, Pittsburgh, PA, USA); Light microscopy
poly/bed 812 resin (Ted Pella Inc., R e dding, CA, Culture dishes were fixed in 100% methanol, stained
USA); human recombinant IGF-I (Collaborative Re- with 3% toluidine blue, and photographed on a Leitz
search, Waltham, MA, USA); intact, human recombi- microscope on Kodak DX 100 black and white film.
nant IGFBP-5 (Chiron Corp., Emeryville, CA, USA),
IGFBP-5 peptide (AA201-218, RKGFYKRKQCKPS Fluorescence microscopy
RGRKR; Fred Hutchinson Cancer Research Center, Se- Mesangial cells were plated as described earlier here
attle, WA, USA); and bradykinin (Sigma). and were treated with IGF-I (10 nmol/L), IGFBP-5201-218
(30 mg/mL), or bradykinin (10 ng/mL) and were stainedCell culture
for evidence of GTPase activation. Chamber slides were
Rat glomerular MCs were prepared by modification rinsed in phosphate-buffered saline (PBS) and fixed in
[13, 14] of routine methods [16]. Minced rat kidney cortex 2% paraformaldehyde for 20 minutes. After rinsing in
was sieved, and glomeruli were isolated and plated in PBS, cells were permeabilized with 0.01% triton X-100
medium containing a 1:1 mix of 20% fetal calf serum for three minutes and then rinsed three times in PBS.
(FCS)-RPMI 1640 and previously collected glomerular Slides were incubated with primary antibody to b-actin
conditioned medium [13]. The supplemental insulin rou- (1:1000), vinculin (1:400), Rac1 (1:400), Cdc42GAP
tinely added to MC cultures was omitted. MC outgrowths (1:200), or IQGAP1 (1:200) for 20 minutes at room tem-
were harvested and passed in this medium for an addi- perature and were rinsed and incubated with FITC-con-
tional week, after which the conditioned medium was jugated secondary antibody for an additional 20 minutes.
omitted. MCs were cloned and studied at passages 8 Controls included the nonimmune IgG and the second-
through 12. ary antibody alone. Two different antigens were visual-
ized by using a Cy3-conjugated, as well as a FITC-conju-
Migration and phenotypic change gated, secondary antibody. To visualize f-actin, slides
The effects of IGFBP-5 on MC migration were exam- were stained with 12.5 mg/mL of Bodipy phalloidin for 20
ined at 24 and 48 hours on three separate occasions. minutes at room temperature. All slides were mounted
Migration was examined in a wounding assay as de- in Fluoromount and observed with a Leitz microscope
scribed previously [15]. In brief, MCs were plated in equipped with epi-illumination. The fluorescent images
60 mm tissue culture dishes, grown to near confluency, were recorded on Kodak DX 400 black and white film
growth arrested in 2% FCS-RPMI, and scraped with a or Ektachrome color slide film.
sterile razor blade to create a linear wound across the
Electron microscopydish. IGF-I (10 nmol/L), IGFBP-5 (30 nmol/L), IGFBP-
5201-218 peptide (1 to 30 mg/mL), or staurosporin (50 Slide cultures of MCs were rinsed with PBS and fixed
nmol/L) were then added to the cultures, and MC migra- in 2% gluteraldehyde for two hours at 48C, treated with
tion was examined 48 hours later. For studies on the rapid 1% osmium tetroxide for 30 minutes at room tempera-
effects of additives to cell migration, the experimental ture, and washed three times with cacodylate buffer.
medium was removed after 30 minutes, and cells were They were sequentially dehydrated through ascending
left in control media for the rest of the test period. Con- concentrations of alcohol (35 to 100%) to resin and par-
trols were maintained in 2% FCS-RPMI media. Cultures tially polymerized at room temperature overnight [17].
were stained with 3% toluidine blue, and migrating cells Capsules filled with medcast were placed over the sec-
along 1 mm length of the wound edge were counted in 0.1 tions of cells and polymerized at 708C overnight. The
capsules over layers of cells were carefully snapped offmm increments. Five areas were examined per sample.
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migration, the migratory pattern and phenotype of indi-
viduals cells were strikingly different (Fig. 2). For exam-
ple, untreated MCs became elongated during migration,
and IGF-I–treated cells developed a “kite-like” mor-
phology with a large advancing lamellipodia. In contrast,
MCs treated with intact IGFBP-5 or IGFBP-5201-218 devel-
oped filopodia that extended in multiple directions with-
out the formation of lamellipodia. This formation of
extensive filopodia without a leading lamella has not
been described previously in migrating MC cells.
IGFBP-5201-218 rapidly redistributes cytoskeletal actin
Phalloidin staining of f-actin containing stress fibers
(Fig. 3) shows that untreated, nonmigrating MCs have an
extensive network of stress fibers that disappear within
one hour of IGFBP-5201-218 treatment. In the IGFBP-52019-218–
treated cells, peripheral rings and aggregates of f-actin
form below the cell membrane, and microspike and filo-
podial formations are seen. By 24 hours, few stress fibers
remain, and f-actin aggregates are present both around
the nucleus and along the filopodia. At this stage, the
Fig. 1. Mesangial cell (MC) migration induced by increasing concentra- filopodia become very long cellular extensions.tions of insulin-like growth factor binding protein-5201-218 (IGFBP-5201-218).
In most migrating cells, b-actin organizes below theThe number of migrating MCs at 48 hours is plotted (% of control)
after treatment with increasing concentrations of IGFBP-5201-218. The plasma membrane in the leading lamella where it cross-
results are expressed as the mean 6 SEM. *P , 0.001, analysis of links with myosin to facilitate locomotion [4]. In untreatedvariance, N 5 5 to 6 per condition.
MCs, b-actin is granular in appearance and is finely dis-
persed throughout the cell (Fig. 3b). Within one hour of
treatment with IGFBP-5201-218, areas of the cytoplasm be-after heating to 908C. In order to achieve the desired
orientation, embedded cells were sawed apart and re- come devoid of b-actin, and aggregates of b-actin are
concentrated in selected peripheral areas (Fig. 3d), giv-mounted. A Sorvall MT6000 ultramicrotome was used
for serial sectioning, and specimens were examined on ing the appearance that the cells may have more than
one leading edge. This is more pronounced by 24 hours,a transmission electron microscope (JOEL TEM S100,
Tokyo, Japan). when b-actin is concentrated along the edges of the filo-
podial extensions.
Statistical analysis
Characterization of focal attachments induced byGroup means were compared by one-way analysis of
treatment with IGFBP-5201-218variance (ANOVA). P , 0.05 was considered significant.
As seen by staining for vinculin, untreated MCs have
multiple, finely dispersed cell–matrix adhesions around
RESULTS
the cell periphery, with occasional large focal adhesions
IGFBP-5201-218 induces MC migration with extensive between cells (Fig. 4). Within 15 minutes after the addi-
filopodia formation tion of IGFBP-5201-218, organized vinculin spicules are de-
tached from cell membrane anchors, as they appear someRat MC migration was examined in a wounding assay.
As shown previously, IGF-I, intact IGFBP-5, and the distance inside of the cell membrane (data not shown).
By two hours after the addition of IGFBP-5201-218, theheparin-binding domain of IGFBP-5, IGFBP-5201-218, stim-
ulate MC migration [15]. Intact IGFBP-5 induces less of peripheral vinculin spikes are dim and thin, and strips
of cytoplasmic areas are devoid of vinculin (Fig. 4b).a response than IGF-I or the IGFBP-5 peptide because
the amino terminal portion of IGFBP-5 inhibits the ef- After 24 hours, faintly stained, diffused vinculin can be
seen throughout the cell body, and bright clusters offects of endogenous IGF-I, whereas the carboxy terminal
peptide has only direct, stimulatory effects on the MCs vinculin are noted only in focal sites along the course of
the filopodia (Fig. 4c). These sites correspond in location[15]. These direct stimulatory effects can be reproduced
by the heparin-binding peptide, and concentrations of to the areas where f-actin terminates (Fig. 3e). Cell mem-
brane of filopodial extensions can be seen beyond theseIGFBP-5201-218 above 7 mg/mL stimulate MC migration
in a dose-dependent manner (Fig. 1). attachment sites.
The disappearance of vinculin spicules and focal adhe-Although both IGF-I and IGFBP-5 stimulated MC
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Fig. 2. Phenotypes of migrating MCs. Cells were stained with toluidine blue after 48 hours of treatment with IGF-I (10 nmol/L; b), intact IGFBP-5
(100 nmol/L; c), or IGFBP-5201-218 (30 mg/mL; d ) and were examined by light microscopy. As compared with untreated MCs (a), IGF-I–stimulated
cells assumed a “kite-like” shape with a unidirectional leading lamella (b). In contrast, IGFBP-5 (c) and IGFBP-5201-218 (d) stimulated cells formed
multiple filopodial extensions that were multidirectional (arrow, d). Magnification 3400.
sions and the concentration of vinculin clusters in only a ated with the IGFBP-5–induced changes in actin reorga-
nization. Activated Cdc42 binds GTP and forms a homo-few focal areas of filopodia suggest that IGFBP-5201-218
induced a unique mechanism of cell anchoring. To evalu- dimer [18], which binds Cdc42GAP with high affinity
ate this further, sagittal sections of MCs were examined [19]. As an indication of Cdc42 activation, the intensity
by transmission electron microscopy (Fig. 5). The elec- and location of staining for Cdc42GAP were examined
tron micrographs represent a section through the cell in untreated and IGFBP-5201-218–treated MCs. Using dual
body and the length of one cellular extension. Untreated staining with phalloidin and antibody to Cdc42GAP, nu-
MCs lay flat and are attached to the substratum. In con- merous stress fibers and minimal endogenous perinu-
trast, IGFBP-5201-218–treated cells are attached by an occa- clear Cdc42 activity were detected in quiescent, un-
sional broad “foot” along the length of each long filo- treated MCs (Fig. 6). Within 15 minutes of treatment
podial extension, with the remainder of the cell being with IGFBP-5201-218, multiple protruding microspikes or
suspended above the substratum. Microspikes were ap- short filopodia were apparent. This was associated with
parent at the ends of the long suspended sections of the reorganization of stress fibers and increased staining for
cell. Higher magnification of a “foot” shows attachment Cdc42GAP. Initially, large aggregates of Cdc42GAP
to underlying matrix (Fig. 5e). were observed near the cell membrane, and within one
hour, clusters were detected surrounding the nucleus
Cdc42GAP rapidly reorganizes after the (Fig. 6b). After 24 hours (Fig. 6c), the IGFBP-5201-218–
addition of IGFBP-5201-218 treated cells were phenotypically modified with f-actin
fibers in the periphery and extensive filopodia. Cdc42The GTPases, Rho, Cdc42, and Rac, modulate cellular
functions such as gene expression, growth, motility, and activation appeared to persist as staining for Cdc42GAP
continued to be bright around the nucleus.cytoskeletal architecture. Because Cdc42 activation is
preferentially associated with filopodia formation [10], For further confirmation of Cdc42 activity, MCs were
dual stained with antibody to IQGAP1. This proteinwe next examined whether Cdc42 activation was associ-
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Fig. 3. Cytoskeletal reorganization induced by IGFBP-5201-218. MCs were stained with phalloidin to show f-actin filaments and stress fibers (a, c,
and e). Untreated MCs have abundant stress fibers that crisscross the cell in all directions (a). Within one hour of treatment with IGFBP-5201-218,
actin is rapidly reorganized (c). A dense peripheral ring of actin is seen under the plasma membrane, and early filopodia are seen protruding from
the cell (arrows). At 24 hours, the central zone of the cell is quite condensed, and many filopodial extensions are apparent. f-Actin fibers extend
into and condense in these projections. Staining for b-actin is shown (b, d, and f ). In untreated MCs, b-actin is diffusely distributed throughout
the cell. One hour after adding IGFBP-5201-218, b-actin is concentrated in small peripheral areas (arrows). By 24 hours (f), focal aggregates of b-actin
are seen throughout the cell and particularly in isolated sites along the filopodial extensions (magnification 3400).
binds to GTP-Cdc42 and coprecipitates and colocalizes Bradykinin activates Cdc42 with subsequent filopodia
formation in Swiss 3T3 cells [22]. Treatment of MCs withwith Cdc42 when it is activated [20, 21]. At one hour,
MCs treated with IGFBP-5201-218 had increased intensity bradykinin serves as a positive control, as it also leads
to Cdc42GAP aggregation in MCs (Fig. 7f).and aggregation of staining for both Cdc42GAP and
IQGAP1 (Fig. 7 c, d). In contrast, IGF-I–treated MCs, In migration stimulated by growth factors such as
IGF-I, Rac is the predominant Rho-GTPase that be-which also undergo a phenotypic change that covers a
smaller surface area as they detach from peripheral fo- comes activated prior to lamellipodia formation [10]. To
determine whether Rac had a role in IGFBP-5 signaling,cal adhesions, do not show a change in staining for
Cdc42GAP (Fig. 7e) or IQGAP1 (data not shown). cells were stained for Rac-1 at multiple times from 5
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Staurosporin inhibits IGFBP-5201-218–induced
MC migration, Cdc42 activity, and
cytoskeletal reorganization
Because the IGFBP-5 receptor has serine/threonine
kinase activity [23], we examined whether early inhibi-
tion of serine/threonine kinase activity would prevent
MC migration and activation of Cdc42. The nonspecific
serine/threonine kinase inhibitor staurosporin had no
effect on migration of untreated MCs or on the migration
induced by IGF-I. In contrast, when added simultane-
ously with IGFBP-5201-218, staurosporin completely blocked
the IGFBP-5–induced MC migration (Fig. 9). In these
experiments, the medium was changed at time 0, and
the additives remained in the medium until the cells were
processed for staining and counting 48 hours later.
As the effects of IGFBP-5 to stimulate cytoskeletal
reorganization and staining of Cdc42GAP occurred
within 5 to 15 minutes of adding IGFBP-5 and the effects
of staurosporin were short lived, we examined the time
course of IGFBP-5–induced migration and its inhibition
by staurosporin. As shown in Figure 10, IGFBP-5201-218
could be removed after 30 minutes, and the increase in
migrating cells was comparable to that observed when
the ligand remains in the medium for the entire 48 hours.
Staurosporin effectively blocked IGFBP-5–induced mi-
gration when it was added together with IGFBP-5 for
the first 30 minutes or for the next 30 minutes following
the removal of IGFBP-5201-218. Staurosporin had no effect
on IGFBP-5–induced migration when it was added 1.5
hours after the removal of IGFBP-5201-218.
Similarly, when IGFBP-5201-218 was removed after 30 min-
utes, Cdc42GAP staining increased and remained high for
48 hours (Fig. 11), consistent with its anticipated role in
mediating MC migration. MCs treated with IGFBP-5201-218
and staurosporin were stained for Cdc42GAP at 1, 4, and
24 hours. Staurosporin effectively blocked the changes in
staining intensity and location for Cdc42GAP when it
was added either with IGFBP-5201-218 during the first 30
minutes or for the next 30 minutes after the removal of
IGFBP-5201-218 (Fig. 11c). Blockade of early IGFBP-5201-218
Fig. 4. IGFBP-5201-218–induced reorganization of focal adhesions. Cells stimulation by staurosporin not only reduced MC move-were stained with antibodies to vinculin and examined by indirect immu-
ment to migration rates equal to untreated cells, but itnofluorescence. Peripheral vinculin spicules are seen in untreated MCs
(a) as evidence of many focal adhesions. Within two hours of treatment also prevented the change in cell phenotype.
with IGFBP-5201-218, vinculin staining appears diffuse and less intense
(b). Brightly stained peripheral spicules are no longer present. After
24 hours of treatment, focal brightly stained areas of vinculin are seen DISCUSSIONalong the filopodial cell extensions (c). Magnification 3400.
Although IGFBP-5 is known to interact with IGF-I
to enhance or inhibit IGF-I action [24–26], our studies
with MCs (present and previous) [11, 12, 15, 27] haveminutes to 24 hours after adding IGFBP-5201-218. As shown
shown that IGF-I and IGFBP-5 have different effectsin Figure 8, Rac-1 staining was minimal in untreated MCs
on proliferation, phenotype, cytoskeletal organization,or those treated with IGFBP-5201-218, whereas activation of
and mechanisms of locomotion. Furthermore, the regionRac-1 by IGF-I was apparent within five minutes (Fig.
of IGFBP-5 known to interact with and phosphorylate8c). Minimal change in intensity of staining for Rac-1
the IGFBP-5 receptor IGFBP-5201-218 does not bind IGF-Iwas seen in IGFBP-5201-218–treated cells at two and four
hours (data not shown). or the IGF-I receptor [23]. These observations support a
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Fig. 5. Substratum attachments of migrating MCs treated with IGFBP-5201-218. A light micrograph of IGFBP-5201-218–treated cells is shown in (a)
for orientation. (b) Untreated MCs are adherent to the substratum The electron micrographs (c–e) represent sagittal sections through the cell
body and one of the long filopodial extensions of IGFBP-5201-218–treated MCs. In the cells, the cell body, as well as the filopodial extensions, is
lifted off of the substratum, except for an occasional attached region. (d) Two adjacent cells are seen making contact with the tips of the filopodia.
A higher magnification of a “foot” shows matrix below the “foot” and attachments to it (e, arrow). Magnifications 35000, except for (e), which
is 330,000.
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Fig. 6. Dual staining of MCs for f-actin and
Cdc42GAP. Untreated MCs (a) show f-actin
filaments spanning the cells in all directions
(green). Small amounts of Cdc42GAP are seen
as granular perinuclear staining (yellow/orange).
Within one hour of exposure to IGFBP-5201-218
(b), f-actin rearranges to form a peripheral ring
under the plasma membrane. Concomitantly,
the intensity of Cdc42GAP staining has mark-
edly increased with large perinuclear aggre-
gates. Early filopodial extensions are apparent
(b). After 24 hours of IGFBP-5201-218 stimula-
tion, long cellular extensions containing f-actin
are present (c). Cdc42GAP staining remains
prominent, although it becomes less granular
in appearance. Original magnification 3400.
Publication of this figure in color was made
possible by Merck & Co., Seattle, Washington,
USA.
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Fig. 7. Dual staining of MCs for Cdc42GAP and IQGAP1. Cells were stained with antibodies to Cdc42GAP (a, c, e, and f) and IQGAP1 (b and d)
one hour after the medium was changed. In untreated MCs (a and b), Cdc42GAP and IQGAP1 appear as faint, diffuse, fine granular cytoplasmic
staining. IGFBP-5201-218 (30 mg/mL) treatment is associated with bright aggregation of Cdc42GAP (c), which colocalizes with IQGAP1 (d). In
contrast, no change in staining for Cdc42GAP is observed after the addition of IGF-I (10 nmol/L) despite its affect on cell shape (e). Bradykinin,
a substance known to activate Cdc42, is associated with aggregation of Cdc42GAP (f). Original magnification 3400.
direct role for IGFBP-5 in mediating important biologic The finding that IGFBP-5201-218–stimulated cells pos-
effects on MCs. We have shown that IGFBP-5 stimulates sessed such a unique phenotype was unexpected, as cur-
cellular migration by mechanisms that have not been rent models of cellular migration have not included a
described previously. IGFBP-5 and its carboxy-terminal spider-like morphology or a “raised body” method of
peptide IGFBP-5201-218 induced rapid cytoskeletal reorga- locomotion. By electron microscopic examination, the
nization and the formation of filopodia, which did not
thin filopodia are suspended above the surface by broadprogress to a broad leading lamella. This phenotype of
attachments (Fig. 5) in contrast to IGF-I–stimulated mi-very long filopodia extending out from the cell-like
grating cells, which remain attached throughout [27].spokes of a wheel also included the novel finding of rare
While the biochemical makeup of these attachments issubstratum adhesions along each filopodium that raised
the cell above the substratum. unknown, it is unlikely that they are adherent to vitronec-
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Fig. 9. Staurosporin inhibits IGFBP-5201-218–stimulated migration. MC
migration was measured at 48 hours after wounding. In these experi-
ments, the agents were added at time 0 and left in the medium for the
entire 48 hours. The medium additives are IGFBP-5201-218 (30 mg/mL),
IGF-I (10 nmol/L), and staurosporin (50 nmol/L). The results are ex-
pressed as the mean 6 SEM. *P , 0.001, ANOVA, N 5 5 per condition.
The actin cytoskeleton, via polymerization, cross-link-
ing, and regulation of focal complexes, provides protru-
sive and contractile forces needed for cell migration [30,
32–34]. The regulation of these activities are controlled
by the Rho family of GTPases, Rho, Rac, and Cdc42 [9,
10, 35–37]. Growth factors such as insulin, IGF-I, and
PDGF activate Rac and induce directional migration
with a leading lamella. Our observation that filopodia
formation was the predominant morphologic change in-
duced by IGFBP-5 suggested that Cdc42 was preferen-Fig. 8. Staining of MCs for Rac-1. No significant staining for Rac-1
was observed in untreated MCs (a) or at five minutes after adding tially activated [10]. Our finding that Cdc42GAP staining
IGFBP-5201-218 (30 mg/mL; b). A significant increase in staining for Rac-1 became prominent within minutes of IGFBP-5201-218 treat-was apparent after treatment with IGF-I (10 nmol/L; c). Original magni-
ment is consistent with the likelihood that IGFBP-5 re-fication 3400.
ceptor occupancy leads to activation of Cdc42. Colocaliza-
tion of IQGAP1 with Cdc42GAP further supports Cdc42
activation, as IQGAP binds to the Cdc42 complex onlytin, as the avb3 disintegrin kistrin has no effect on IGFBP-
when it is activated [21]. We do not believe that aggrega-5–induced migration [15, 28]. Additional studies will be
tion of Cdc42GAP and colocalization with IQGAP1 isneeded to define these attachments and the ways in
merely a visual consequence of a change in cell phenotypewhich they detach and reform during locomotion, as well
for several reasons. Treatment with IGF-I ultimately leadsas the association with Cdc42 in mediating actin-linked
to a thin, bipolar phenotype [15], which is not associatedfocal complexes [10], integrin activation [29], cell adhe-
with aggregation of Cdc42GAP at any stage in the evolu-sion [30], and anchorage-independent growth [31]. These
tion of that change in phenotype. The aggregation ofwill be challenging studies given the limited number of
these “broad feet” on each cell. Cdc42GAP in IGFBP-5–treated MCs precedes a marked
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Fig. 10. Time-dependent inhibition of MC migration by staurosporin.
MC migration expressed as percentage of control was measured 48
hours after wounding. IGFBP-5201-218 (30 mg/mL) was added at the time
of wounding for 30 minutes and then removed by washing with PBS.
Staurosporin (50 nmol/L) was added for 30 minutes at the times shown
and then removed by washing. *P , 0.05, ANOVA, N 5 5 per condition.
change in cell shape. Also, bradykinin, a substance
known to activate Cdc42 [22], serves as a positive control,
as it induces aggregation of Cdc42GAP in MCs.
Our use of Cdc42GAP and IQGAP1 antibodies to
demonstrate Cdc42 activation complements cellular
transfection studies that utilized Cdc42 constructs to
stimulate filopodia formation [38]. Studies of the Cdc42
cascade, independent of Rac-1, have been difficult to
evaluate in biologic systems, as Rac is often endoge-
nously activated [10, 39]. Bradykinin treatment of fibro-
blasts is a good example as it initially activates Cdc42
and filopodia formation [22]. The study of the Cdc42/
filopodia portion of the cascade requires blockade of Fig. 11. Inhibition by staurosporin of IGFBP-5201-218–induced reorgani-
endogenous Rac; otherwise, it becomes rapidly acti- zation of Cdc42GAP. MCs were treated with IGFBP-5201-218 (30 mg/mL)
for 30 minutes and then incubated with or without staurosporin (50vated, leading to the formation of a lamella. Our failure
nmol/L) for 30 minutes. Four hours later, cells were stained with anti-to show changes in Rac-1 staining in IGFBP-5–activated body to Cdc42GAP. (a) Untreated controls. (b) IGFBP-5201-218 alone.
MCs is not due to a lack of Rac, as IGF-I treatment (c) IGFBP-5201-218 plus staurosporin. Original magnification 3400.
rapidly activated Rac, followed by formation of large
lamellapodia. It is of note that early staining for Rac-1 in
IGFBP-5–treated cells appears diminished as compared
Considerable data show that transfection of Cdc42with untreated controls. Although the sensitivity of this
constructs is followed by activation of IQGAP [20, 21],method does not allow specific quantitation, this obser-
p21-activated protein kinase (PAK) [40], and the Wis-vation suggests that IGFBP-5201-218 may actively suppress
cott-Aldrich protein (WASP) [38]; however, little isRac-1 activity. IGFBP-5201-218 treatment of migrating MCs
known about the initial signals that activate Cdc42. Theoffers an ideal model to study the biological consequence
of Cdc42 activation and filopodia formation. results of our studies suggest that the serine/threonine
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